Fluorescence method for determining the mechanism and speed of action of surface-active drugs on yeast cells

BioTechniques

Volumn 50, Issue 1, 2011, Pages 58-63

  Kodedová, Marie ^a   Sigler, Karel ^b   Lemire, Bernard D ^c   Gášková, Dana ^a  

^a CHARLES UNIVERSITY   (Czech Republic)

^b INSTITUTE OF MICROBIOLOGY   (Czech Republic)

^c UNIVERSITY OF ALBERTA   (Canada)

Author keywords

Cell permeabilization; Fluorescent dye dis c3(3); Membrane potential; Surface active drug

Indexed keywords

AMPHOTERICIN B; BENZALKONIUM CHLORIDE; NYSTATIN; OCTENIDINE;

ARTICLE; CELL MEMBRANE PERMEABILITY; DRUG MECHANISM; FLUORESCENCE; NONHUMAN; SACCHAROMYCES CEREVISIAE; YEAST CELL;

AMPHOTERICIN B; ANTIFUNGAL AGENTS; BENZALKONIUM COMPOUNDS; CELL MEMBRANE PERMEABILITY; KINETICS; MICROBIAL SENSITIVITY TESTS; NYSTATIN; PYRIDINES; SACCHAROMYCES CEREVISIAE; SODIUM DODECYL SULFATE; SPECTROMETRY, FLUORESCENCE; SURFACE-ACTIVE AGENTS;

SACCHAROMYCES CEREVISIAE;

EID: 78751563039     PISSN: 07366205     EISSN: 19409818     Source Type: Journal    
DOI: 10.2144/000113568     Document Type: Article

References (34)

1. Anaissie, E. 1992. Opportunistic mycoses in the immunocompromised host: experience at a cancer center and review. Clin. Infect. Dis. 14(Suppl 1):S43-S53.
2. Marr, K.A. and R.A. Bowden. 1999. Fungal infections in patients undergoing blood and marrow transplantation. Transpl. Infect. Dis. 1:237-246.
3. Warnock, D.W. 2007. Trends in the epidemiology of invasive fungal infections. Jpn. J. Med. Mycol. 48:1-12.
4. Carrillo-Muñoz, A.J., G. Giusiano, P.A. Ezkurra, and G. Quindós. 2006. Antifungal agents: mode of action in yeast cells. Rev. Esp. Quimioter. 19:130-139.
5. Odds, F.C., A.J.P. Brown, and N.A.R. Gow. 2003. Antifungal agents: mechanisms of action. Trends Microbiol. 11:272-279.
6. Anderson, J.B., N. Ricker, and C. Sirjusingh. 2006. Antagonism between two mechanisms of antifungal drug resistance. Eukaryot. Cell 5:1243-1251.
7. Cowen, L.E. and W.J. Steinbach. 2008. Stress, drugs, and evolution: the role of cellular signaling in fungal drug resistance. Eukaryot. Cell 7:747-764.
8. Barrett, D. 2002. From natural products to clinically useful antifungals. Biochim. Biophys. Acta 1587:224-233.
9. DiDomenico, B. 1999. Novel antifungal drugs. Curr. Opin. Microbiol. 2:509-515.
10. Geor gopapadakou, N.H. 1998. Antifungals: mechanism of action and resistance, established and novel drugs. Curr. Opin. Microbiol. 1:547-557.
11. Monk, B.C. and A. Goffeau. 2008. Outwitting multidrug resistance to antifungals. Science 321:367-369.
12. Onyewu, C. and J. Heitman. 2007. Unique applications of novel antifungal drug combinations. Anti-Infect. Agents Med. Chem. 6:3-15.
13. Benincasa, M., M. Scocchi, S. Pacor, A. Tossi, D. Nobili, G. Basaglia, M. Busetti, and R. Gennaro. 2006. Fungicidal activity of five cathelicidin peptides against clinically isolated yeasts. J. Antimicrob. Chemother. 58:950-959.
14. Monk, B.C. and D.R.K. Harding. 2005. Peptide motifs for cell-surface intervention: application to anti-infective and biopharmaceutical development. BioDrugs 19:261-278.
15. Monk, B.C., K. Niimi, S. Lin, A. Knight, T.B. Kardos, R.D. Cannon, R. Parshot, A. King, et al. 2005. Surface-active fungicidal D-peptide inhibitors of the plasma membrane proton pump that block azole resistance. Antimicrob. Agents Chemother. 49:57-70.
16. Cox, S.D., C.M. Mann, J.L. Markham, H.C. Bell, J.E. Gustafson, J.R. Warmington, and S.G. Wyllie. 2000. The mode of antimicrobial action of the essential oil of Melaleuca alternifolia (tea tree oil). J. Appl. Microbiol. 88:170-175.
17. Bennis, S., F. Chami, N. Chami, T. Bouchikhi, and A. Remmal. 2004. Surface alteration of Saccharomyces cerevisiae induced by thymol and eugenol. Lett. Appl. Microbiol. 38:454-458.
18. Janderová, B., D. Gášková, and O. Bendová. 1995. Consequences of Sporidiobolus pararoseus killer toxin action on sensitive cells. Folia Microbiol. (Praha) 40:165-167.
19. 3 (3) assay in Saccharomyces cerevisiae. Yeast 14:1189-1197.
20. Čadek, R., K. Chládková, K. Sigler, and D. Gášková. 2004. Impact of the growth phase on the activity of multidrug resistance pumps and membrane potential of S. cerevisiae: effect of pump overproduction and carbon source. Biochim. Biophys. Acta 1665:111-117.
21. 3 (3) in yeast. Biochim. Biophys. Acta 1511:74-79.
22. Hendrych, T., M. Kodedová, K. Sigler, and D. Gášková. 2009. Characterization of the kinetics and mechanisms of inhibition of drugs interacting with the S. cerevisiae multidrug resistance pumps Pdr5p and Snq2p. Biochim. Biophys. Acta 1788:717-723.
23. +-ATPase inhibitors in yeast. Folia Microbiol. (Praha) 42:252-254.
24. Decottignies, A., A.M. Grant, J.W. Nichols, H. de Wet, D.B. McIntosh, and A. Goffeau. 1998. ATPase and multidrug transport activities of the overexpressed yeast ABC protein Yor1p. J. Biol. Chem. 273:12612-12622.
25. 3 (3) fluorescence. Folia Microbiol. (Praha) 42:221-224.
26. Heerklotz, H. 2008. Interactions of surfactants with lipid membranes. Q. Rev. Biophys. 41:205-264.
27. le Maire, M., P. Champeil, and J.V. Møller. 2000. Interaction of membrane proteins and lipids with solubilizing detergents. Biochim. Biophys. Acta 1508:86-111.
28. 3 (3) assay. Int. J. Biochem. Cell Biol. 31:575-584.
29. Bolard, J. 1986. How do the polyene macrolide antibiotics affect the cellular membrane properties? Biochim. Biophys. Acta 864:257-304.
30. Zotchev, S.B. 2003. Polyene macrolide antibiotics and their applications in human therapy. Curr. Med. Chem. 10:211-223.
31. Baginski, M. and J. Czub. 2009. Amphotericin B and its new derivatives-mode of action. Curr. Drug Metab. 10:459-469.
32. Hübner, N.O., J. Siebert, and A. Kramer. 2010. Octenidine dihydrochloride, a modern antiseptic for skin, mucous membranes and wounds. Skin Pharmacol. Physiol. 23:244-258.
33. Day, S., P. Lalitha, S. Haug, A.W. Fothergill, V. Cevallos, R. Vijayakumar, N.V. Prajna, N.R. Acharya, et al. 2009. Activity of antibiotics against Fusarium and Aspergillus. Br. J. Ophthalmol. 93:116-119.
34. McDonnell, G. and A.D. Russell. 1999. Antiseptics and disinfectants: activity, action, and resistance. Clin. Microbiol. Rev. 12:147-179.